238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort
François Cherifi, Luc Cabel, C. Bousrih, E. Volant, F. Dalenc, Benoîte Méry, Mathieu Kuentz, Teresa Alexandre, L. Benistant, M. Leheurteur, Caroline Bailleux, M. Debled, Jean‐Sébastien Frenel, D. Loirat, F-C Bidard, Sonja Aho, A. Glenet, J.T.L. Ribeiro Mourato, François Christy, George Emile
Topics & Concepts
MedicineTriple-negative breast cancerPembrolizumabCohortOncologyBreast cancerInternal medicineCancerImmunotherapyBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies